Prediction of Response to Certolizumab Pegol Treatment by Functional Mri of the Brain: An International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial (Precepra)

Results

Naziv:	Prediction of Response to Certolizumab Pegol Treatment by Functional Mri of the Brain: An International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial (Precepra)
Autori :	Rech, Juergen; ...; Damjanov, Nemanja S; ...; (broj, koautora 24)
Godina:	2020
Publikacija:	ANNALS OF THE RHEUMATIC DISEASES
ISSN:	0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 79 br. Suppl 1 str. 952-956
DOI:	10.1136/annrheumdis-2020-eular.4288
WoS-ID:	000555905003124
URI:	https://enauka.gov.rs/handle/123456789/810187
Projekat:	UCB Biopharma SPRL, Brussels, Belgium
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Altmetric

Dimensions

Unpaywall

Google Scholar^TM